Development and experimental application of receptor-specific MR contrast media;ENTWICKLUNG UND EXPERIMENTELLER EINSATZ VON REZEPTORSPEZIFISCHEN MR-KONTRASTMITTELN

Radiologe

Volumn 36, Issue 2, 1996, Pages 153-163

  Reimer, P ^a   Weissleder, R ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

function; receptors; specific attachment

Indexed keywords

CONTRAST MEDIUM;

ANIMAL MODEL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; HEPATITIS; LIVER CELL CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREATITIS; REVIEW;

ANIMALS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMAGE ENHANCEMENT; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; PANCREAS; PANCREATIC NEOPLASMS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; RECEPTORS, DRUG;

EID: 0029932615     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001170050053     Document Type: Review

References (77)

1. Achord D, Brot F, Sly W (1977) Inhibition of the rat clearance system for agalacto-orosomucoid by yeast mannans and by mannose. Biochem Biophys Res Commun 77: 409-415
2. Andersson G, Rissler P, Eriksson L (1988) Asialoglycoprotein receptors in rat liver nodules. Carcinogenesis 9: 1623-1628
3. Ashwell G, Harford J (1982) Carbohydrate-specific receptors of the liver. Ann Rev Biochem 51: 531-554
4. Baenzinger J, Maynard Y (1980) Human hepatic lectin. J Biol Chem 255: 4607-4613
5. Beuth J, Ko H, Oette K, Pulverer G, Roszkowski K, Uhlenbruck G (1987) Inhibition of liver metastasis in mice by blocking hepatocyte lectins with arabinogalactan infusions and D-galactose. J Cancer Res Clin Oncol 113: 51-55
6. Bogdanov A, Papisov M, Weissleder R, Shen T, Brady T (1992) Opsonization of dextran-stabilized iron oxides with plasma proteins. Society of Magnetic Resonance in Medicine, 11th Annual Meeting 1: 864
7. Brasch R (1992) New directions in the development of MR imaging contrast media. Radiology 183: 1-11
8. Brown T, Henderson L, Thorpe S, Baynes J (1978) The effect of a-mannose-terminal oligosaccharides on the survival of glycoproteins in the circulation. Arch Biochem Biophys 188: 418-428
9. Cerdan S, Lötscher H, Künnecke B, Seelig J (1989) Monoclonal antibody-coated magnetite particles as contrast agents in magnetic resonance imaging of tumors. Magn Reson Med 12: 151-163
10. Dachman A, Ros P, Goodman Z, Olmsted W, Ishak K (1987) Nodular regenerative hyperplasia of the liver: clinical and radiologic observations. AJR 148: 717-722
11. Douglas B, Woutersen R, Jansen J, de Jong A, Rovati L, Lamers C (1989) Modulation by CR-1409 (Iorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas. Cancer Res 49: 2438-2441
12. Elizondo G, Fretz C, Stark D, Rocklage S, Quay S, Worah D, Tsang Y-M, Chen M, Ferrucci J (1991) Preclinical evaluation of Mn DPDP: new paramagnetic hepatobiliary contrast agent for MR imaging. Radiology 178: 73-78
13. Elizondo G, Weissleder R, Stark D, Guerra J, Garza J, Fretz C, Todd L, Ferrucci J (1990) Hepatic cirrhosis and hepatitis: MR imaging enhanced with superparamagnetic iron oxide. Radiology 174: 797-801
14. Fahlvik A, Bach-Gansino T, Ericsson A, Hemmingson A (1992) Superparamagnetic iron oxide for liver imaging: comparison between three different preparations. 11th Annual Meeting, p 3223
15. Freeman M, Ashkenas J, Rees D, Kingsley D, Copeland N, Jenkins N, Krieger M (1990) An ancient, highly conserved family of cysleine-rich protein domains revealed by cloning type I and type II murine macrophage scavenger receptors. Proc Natl Acad Sci 87: 8810-8814
16. Gehl H, Vorwerk D, Klose K, Günther R (1991) Pancreatic enhancement after low-dose infusion of Mn-DPDP. Radiology 175: 167-174
17. Goldstein J, Anderson R, Brown M (1979) Coated pits, coated vesicles, and receptor-mediated endocytosis. Nature 279: 679-685
18. Groman E, Josephson L, Lewis J (1989) Biologically degradable superparamagnetic materials for use in clinical applications. United States Patent 4, 827-945
19. Hickman J, Ashwell G (1974) Studies on the hepatic binding of asialoglycoproteins by hepatoma tissue and by isolated hepatocytes. In: Tager J, Hooghwinkel G, Daems W (eds) Enzyme therapy in lysosomal storage disease. North-Holland. Amsterdam, pp 169-172
20. Hickman S, Shapiro L, Neufeld E (1974) A recognition marker required for up- take of a lysosomal enzyme by cultured fibroblasts. Biochem Biophys Res Commun 57: 55-61
21. Hubbard A, Wilson G, Ashwell G, Stukenbrok H (1979) An electron microscope autoradiographic study of the carbohydrate recognition systems in rat liver. Cell Biol 83: 47-64
22. Izzo R, Pellecchia C, Praissman M (1988) Internalization and cellular processing of cholecystokinin in rat pancreatic acinar cells. Am J Physiol 255: G738-744
23. Izzo R, Praissman M (1987) Receptor-mediated internalization and secretion of cholecystokinin into rat pancreatic duct fluid. Am J Physiol 253: G445-451
24. Josephson L, Groman E, Menz L, Luis J, Bengale H (1990) A functionalized superparamagnetic iron oxide colloid as a receptor directed MR contrast agent. Magn Reson Imaging 8: 637-646
25. Karlsson S, Ahren B (1989) Effects of three different cholecystokinin receptor antagonists on basal and stimulated insulin and glucagon secretion in mice. Acta Physiol Scand 135: 271-278
26. Kawasaki T, Ashwell G (1976) Chemical and physical properties of an hepatic membrane protein that specifically binds asiatoglycoproteins. J Biol Chem 251: 1296-1302
27. Keppler D, Lesen R, Reutter W, Decker K (1968) Experimental hepatitis induced by D-galactosamine. Exp Mol Pathol 9: 279-290
28. Kolb H, Vogt D, Herbertz L, Corfield A, Schauer R, Schlepper-Schäfer J (1980) The galactose specific lectins on rat hepatocytes and kupffer cells have identical binding characteristics. Hoppe-Seyler's Z Physiol Chem 361: 1747-1750
29. Kolb-Bachhofen H, Schlepper-Schäfer J, Kolb H (1983) Receptor-mediated particle uptake by liver macrophages. The galactoseparticle receptor mediates uptake via coated and also noncoated structures. Exp Cell Res 148: 173-182
30. Kolb-Bachhofen H, Schlepper-Schäfer J, Vogell W, Kolb H (1982) Electron microscopic evidence for an asialoglycoprotein receptor on Kupffer cells: localization of lectin-mediated endocytosis. Cell 21: 859-866
31. Kostaki G, Jacobs I, Zingas A, Klein M, Kling G (1990) Surface coil flash magnetic resonance imaging of the fasting and secretin-stimulated pancreas. Invest Radiol 25: 977-982
32. Kubota K, Som P, Brill A, Sacker D, Meinken G, Srivastava S, Atkins H (1989) Comparative dual-tracer studies of carbon-14 tryptophan and iodine-131 HIPDM in animal models of pancreatic diseases. J Nucl Med 30: 1848-1855
33. Kudo M, Todo A, Ikekubo K, Hino M, Ito H, Yamaguchi H, Saiki Y, Yamamoto K, Yonekura Y, Torizuka K, Horiuchi K, Yokoyama A, Vera D, Stadalnik R (1987) Estimation of hepatic functional reserve by asialoglycoprotein receptor-binding, radiolabeled synthetic ligand "Tc-99m-galactosyl-neoglycolalbumin". Jpm J N Med 24: 1653-1662
34. Lampel M, Kern H (1977) Acute interstitial pancreatitis in the rat induced by excessive doses of pancreatic secretagogue. Virchows Arch [A] 373: 97-117
35. Lewis J, Menz E, Kenny F, Groman E, Josephson L (1990) Vascular magnetic imasing method and agent. WO 90/ 01899
36. Linker C, Schaffer B, Papisov M, Nossiff N, Tsai E, Brady T, Weissleder R (1992) Asialofetuin-coupled monocrystalline iron oxide as an asialoglycoprotein receptor MR imaging agent, 11th Annual Meeting, p 3218
37. Marshall J, Williams S, Jones P, Hepner G (1978) Serum desialyted glycoproteins in patients with hepatobiliary dysfunction. J Lab Clin Med 92: 30-37
38. Meijer D, Scholtens H, Hardonk M (1982) The role of the liver in clearance of glycoproteins from the general circulation, with special reference to intestinal alkaline phosphatase. Pharmaceutisch Weekblad Scientific Edition 4: 57-70
39. Menz E, Rothenberg J, Groman E, Josephson L (1990) Receptor mediated endocytosis type MRI contrast agents. WO 90/01295
40. Molday R, Mackenzie D (1982) Immunospecific ferromagnetic iron-dextran reagents for the labelling and magnetic separation of cells. J Immunol Methods 52: 353-367
41. Otsuki M, Fujii M, Nakamura T, Okabayashi Y, Tanti S, Fujisawa T, Koide M, Baba S (1989) A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas. Dig Dis Sci 34: 857-864
42. Owen C, Sykes N (1984) Magnetic labelling and cell sorting. J Immunol Methods 73: 41-48
43. Petersen O (1984) The mechanism by which cholecystokinin peptides excite their target cells. Biosci Rep 4: 275-283
44. Prieels J, Pizzo S, Glasgow L, Paulson J, Hill R (1978) Hepatic receptor that specificially binds oligosaccharides containing fucosyl a 1-3 N-acetylglucosamine linkages. Proc Natl Acad Sci 75: 2215-2219
45. Reimer P, Shen T, Lee A, Brady T, Weissleder R (1992) Effect of polysaccharide coated iron oxide particles on liver relaxation times. SMRM, 11 th Annual Meeting, p 3224
46. Reimer P, Weissleder R, Brady T, Wittenberg J (1992) Affinity assays allow preclinical evaluation of receptor directed MR contrast agents. Radiology 182. 565-569
47. Reimer P, Weissletier R, Lee A, Buettner S, Wittenberg J, Brady T (1991) Asialoglycoprotein receptor function in benign liver disease: evaluation with MR imaging. Radiology 178: 769-774
48. Reimer P, Weissleder R, Lee A, Wittenberg J, Brady T (1990) Receptor imaging: application to MR imaging of liver cancer. Radiology 177: 729-734
49. Reimer P, Weissleder R, Nickeleit V, Tennant B, Brady T (1992) Animal models for magnetic resonance imaging research of the liver. Invest Radiol 27: 390-393
50. Reutter W, Lesch R, Keppler D, Decker K (1968) Galaktosamin-Hepatitis. Naturwissenschaften 55: 497
51. Saini S, Stark D, Brady T, Wittenberg J, Ferrucci J (1986) Dynamic spin-echo MRI of liver cancer using Gadolinium-DTPA: animal investigation AJR 147: 357-362
52. Sankaran R, Goldfine I, Bailey A, Licko V, Williams J (1982) Relationsship of cholecystokinin receptor binding to regulation of biological functions in pancreatic acini. Am J Physiol 242: G250-G257
53. Sawamura T, Kawasato S, Shiozaki Y, Sameshima Y, Nakada H, Tashiro Y (1981) Decrease of a hepatic binding protein specific for asialoglycoproteins with accumulation of serum asialoglycoprotein in galactosamine-treated rats. Gastroenterology 81: 527-533
54. Sawamura T, Nakada H, Shiozaki Y, Sameshima Y, Tashiro Y (1984) Hyperasialoglycoproteinemia in patients with chronic liver disease and/or liver cell carcinoma. Gastroenterology 87: 1217-1221
55. Schaffer B, Linker C, Papisov M, Tsai E, Nossiff N, Shibata T, Bogdanov A Jr, Brady T, Weissleder R (1993) MION-ASF: biokinetics of an MR receptor agent. MRI 11: 411-417
56. Schwartz A, Marshak-Bothstein A, Rup D, Lodish H (1981) Identification and quantification of the rat hepatocyte asialoglycoprotein receptor. Proc Natl Acad Sci 78: 3348-3352
57. Schwartz A, Rup D, Lodisch H (1980) Difficulties in the quantification of asialoglycoprotein receptors in the rat hepatocyte. J Biol Chem 255: 9033-9036
58. Shen T, Weissleder R, Papisov M, Bogdanov A, Brady T (1993) Monocrystalline iron oxide nanocompounds (MION): physiochemical properties. MRM 29: 599-604
59. Shen T, Weissleder R, Papisov M, Brady T (1991) Polymeric iron oxides for MR imaging. SMRM, 10th Annual Meeting, p 871
60. Shibata T, Weissleder R, Schaffer B, Shen T, Papisov M, Brady T (1992) Tissue relaxivities and detectability of monocrystalline iron oxides, 11th Annual Meeting 1: 1416
61. Shtern F, Garrido L, Compton C, Swiniarski J, Lauffer R, Brady T (1991) MR imaging of blood-borne liver me tastases in mice: contrast enhancement with Fe-EHPG. Radiology 178: 83-89
62. Stadalnik R, Vera D, Woodle E, Trudeau W, Porter B, Ward R, Krohn K, O'Grady L (1985) Technetium-99m NGA functional hepatic imaging: preliminary clinical experience. J Nucl Med 26: 1233-1242
63. Stahl P, Rodman J, Miller M, Schlesinger P (1978) Evidence for receptor-mediated binding of glycoproteins, glycoconjugates, and lysosomal glycosidases by alveolar macrophages. Proc Natl Acad Sci 75: 1399-1403
64. Steer C, Clarenburg R (1979) Unique distribution of glycoprotein receptors on parenchymal and sinusoidal cells of rat liver. J Biol Chem 254: 4457-4461
65. Stockert R, Backer F (1980) Diminished hepatic binding protein for desialyted glycoproteins during chemical hepatocarcinogenesis. Cancer Res 40: 3632-3634
66. Tolleshaug H (1981) Binding and internalization of asialo-glycoproteins by isolated rat hepatocytes. Int J Biochem 13: 45-51
67. Tsang Y, Stark D, Chen M, Weissleder R, Wittenberg J, Ferrucci J (1988) Hepatic micrometastasis in the rat: ferriteenchanced MR imaging. Radiology 167: 21-24
68. Weissleder R, Bogdanov A, Papisov M (1992) Drug targeting in magnetic resonance imaging. Magn Reson Q 8: 55-63
69. Weissleder R, Elizondo G, Wittenberg J, Lee A, Josephson L, Brady T (1990) Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 175: 494-498
70. Weissleder R, Elizondo G, Wittenberg J, Rabito C, Bengele H, Josephson L (1990) Ultrasmall superparamagnetic iron oxide (USPIO): characterization of a new class of MR contrast agents. Radiology 175: 489-493
71. Weissleder R, Lee A, Fischman A, Reimer P, Shen T, Wilkinson R, Callahan R, Brady T (1991) MR antibody imaging: polyclonal human IgG labelled with polymeric iron oxide. Radiology 181: 245-249
72. Weissleder R, Reimer P, Lee A, Wittenberg J, Brady T (1990) MR receptor imaging: Ultrasmall iron oxide particles targeted to asialoglycoprotein receptors. AJR 155: 1161-1167
73. Weissleder R, Stark D, Engelslad B, Bacon B, Compton C, White D, Jacobs P, Lewis J (1989) Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR 152: 167-173
74. Williams J, Sankaran H, Roach E, Goldfine I (1982) Quantitative electron microscopy autoradiographs of 1251-cholecystokinin in pancreatic acini. J Am Physiol 243: G291-G296
75. Wisse E (1970) An electron microscopic study of the fenestrated endothelial lining of rat liver sinusoids. J Ultrastruct Res 31: 125-150
76. Woodle E, Vera D, Stadalnik R, Ward R (1987) Tc-NGA imaging in liver transplantation: preclinical studies. Surgery 102: 55-62
77. Wu G, Wu C, Rubin M (1985) Acetaminophen hepatotoxicity and targeted rescue: a model for specific chemotherapy of hepatocellular carcinoma. Hepatology 5: 709-713